Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults.

Hakkarainen KM, Gyllensten H, Jönsson AK, Andersson Sundell K, Petzold M, Hägg S.

Br J Clin Pharmacol. 2014 Jul;78(1):170-83. doi: 10.1111/bcp.12314.

2.

Prevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adults.

Hakkarainen KM, Andersson Sundell K, Petzold M, Hägg S.

PLoS One. 2013 Sep 4;8(9):e73166. doi: 10.1371/journal.pone.0073166. eCollection 2013.

3.

Risk factors for hospital admissions associated with adverse drug events.

Kongkaew C, Hann M, Mandal J, Williams SD, Metcalfe D, Noyce PR, Ashcroft DM.

Pharmacotherapy. 2013 Aug;33(8):827-37. doi: 10.1002/phar.1287. Epub 2013 May 17.

PMID:
23686895
4.

Methods for assessing the preventability of adverse drug events: a systematic review.

Hakkarainen KM, Andersson Sundell K, Petzold M, Hägg S.

Drug Saf. 2012 Feb 1;35(2):105-26. doi: 10.2165/11596570-000000000-00000. Review.

PMID:
22201475
5.

Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitzer BJ, Shea BF, Hallisey R, et al.

JAMA. 1995 Jul 5;274(1):29-34.

PMID:
7791255
6.

Comparing characteristics of adverse drug events between older and younger adults presenting to a Taiwan emergency department.

Chen YC, Huang HH, Fan JS, Chen MH, Hsu TF, Yen DH, Huang MS, Wang CY, Huang CI, Lee CH.

Medicine (Baltimore). 2015 Feb;94(7):e547. doi: 10.1097/MD.0000000000000547.

7.

Hospital admissions caused by adverse drug events: an Australian prospective study.

Phillips AL, Nigro O, Macolino KA, Scarborough KC, Doecke CJ, Angley MT, Shakib S.

Aust Health Rev. 2014 Feb;38(1):51-7. doi: 10.1071/AH12027.

PMID:
24351707
8.

Incidence of adverse drug events in an academic hospital: a prospective cohort study.

Aljadhey H, Mahmoud MA, Mayet A, Alshaikh M, Ahmed Y, Murray MD, Bates DW.

Int J Qual Health Care. 2013 Dec;25(6):648-55. doi: 10.1093/intqhc/mzt075. Epub 2013 Oct 17.

9.

Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.

Kunac DL, Tatley MV.

Drug Saf. 2011 Jan 1;34(1):59-71. doi: 10.2165/11539290-000000000-00000.

PMID:
21142271
10.

Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.

Kunac DL, Kennedy J, Austin N, Reith D.

Paediatr Drugs. 2009;11(2):153-60. doi: 10.2165/00148581-200911020-00005.

PMID:
19301935
11.

Economic impact of adverse drug events--a retrospective population-based cohort study of 4970 adults.

Gyllensten H, Hakkarainen KM, Hägg S, Carlsten A, Petzold M, Rehnberg C, Jönsson AK.

PLoS One. 2014 Mar 17;9(3):e92061. doi: 10.1371/journal.pone.0092061. eCollection 2014.

12.

Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.

Dequito AB, Mol PG, van Doormaal JE, Zaal RJ, van den Bemt PM, Haaijer-Ruskamp FM, Kosterink JG.

Drug Saf. 2011 Nov 1;34(11):1089-100. doi: 10.2165/11592030-000000000-00000.

PMID:
21981436
13.

Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.

Carnevali L, Krug B, Amant F, Van Pee D, Gérard V, de Béthune X, Spinewine A.

Ann Pharmacother. 2013 Nov;47(11):1414-9. doi: 10.1177/1060028013500939.

PMID:
24285758
14.

Characterising the complexity of medication safety using a human factors approach: an observational study in two intensive care units.

Carayon P, Wetterneck TB, Cartmill R, Blosky MA, Brown R, Kim R, Kukreja S, Johnson M, Paris B, Wood KE, Walker J.

BMJ Qual Saf. 2014 Jan;23(1):56-65. doi: 10.1136/bmjqs-2013-001828. Epub 2013 Sep 19.

15.

Emergency department visits caused by adverse drug events: results of a French survey.

Queneau P, Bannwarth B, Carpentier F, Guliana JM, Bouget J, Trombert B, Leverve X, Lapostolle F, Borron SW, Adnet F; Association Pédagogique Nationale pour l'Enseignement de la Thérapeutique (APNET).

Drug Saf. 2007;30(1):81-8.

PMID:
17194173
16.

Adverse drug events in surgical patients: an observational multicentre study.

de Boer M, Boeker EB, Ramrattan MA, Kiewiet JJ, Dijkgraaf MG, Boermeester MA, Lie-A-Huen L.

Int J Clin Pharm. 2013 Oct;35(5):744-52. doi: 10.1007/s11096-013-9797-5. Epub 2013 May 31.

PMID:
23722455
17.

Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.

Klopotowska JE, Wierenga PC, Stuijt CC, Arisz L, Dijkgraaf MG, Kuks PF, Asscheman H, de Rooij SE, Lie-A-Huen L, Smorenburg SM; WINGS Study Group.

PLoS One. 2013 Aug 5;8(8):e71045. doi: 10.1371/journal.pone.0071045. Print 2013.

18.

Medication errors and adverse drug events in pediatric inpatients.

Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, Goldmann DA.

JAMA. 2001 Apr 25;285(16):2114-20.

PMID:
11311101
19.

Anticoagulation-associated adverse drug events.

Piazza G, Nguyen TN, Cios D, Labreche M, Hohlfelder B, Fanikos J, Fiumara K, Goldhaber SZ.

Am J Med. 2011 Dec;124(12):1136-42. doi: 10.1016/j.amjmed.2011.06.009.

20.

Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.

Benkirane RR, Abouqal R, Haimeur CC, S Ech Cherif El Kettani SS, Azzouzi AA, Mdaghri Alaoui AA, Thimou AA, Nejmi MM, Maazouzi WW, Madani NN, R-Edwards I, Soulaymani RR.

J Patient Saf. 2009 Mar;5(1):16-22. doi: 10.1097/PTS.0b013e3181990d51. Erratum in: J Patient Saf. 2011 Jun;7(2):105. M'daghri Alaoui, Asmae A [corrected to Mdaghri Alaoui, Asmae A]. J Patient Saf. 2010 Mar;6(1):57. R-Abouqal, Redouane [corrected to Abouqal, Redounane].

PMID:
19920434
Items per page

Supplemental Content

Write to the Help Desk